• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种具有常染色体显性遗传的佩罗尼氏病遗传形式的鉴定及其与掌腱膜挛缩症和组织相容性B7交叉反应抗原的关联。

Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompatibility B7 cross-reacting antigens.

作者信息

Nyberg L M, Bias W B, Hochberg M C, Walsh P C

出版信息

J Urol. 1982 Jul;128(1):48-51. doi: 10.1016/s0022-5347(17)52751-2.

DOI:10.1016/s0022-5347(17)52751-2
PMID:6980996
Abstract

Peyronie's disease is an inflammatory disorder with no confirmed etiology. We have documented the familial transmission of the disease as an autosomal dominant trait in 3 pedigrees. The occurrence of Dupuytren's contracture in 7 of 9 (78 per cent) affected individuals, which is a significant increase over the average 0 per cent reported in sporadic cases, suggests that both of these fibrosing disorders are pleiotropic effects of the same gene in these families. Similarly, the histocompatibility B7 cross-reacting antigens were present in 90 per cent of the patients with Peyronie's disease. Additional studies, including careful family histories and histocompatibility antigen typing, are necessary to elucidate the role of histocompatibility antigens as a relative risk factor.

摘要

佩罗尼氏病是一种病因未明的炎症性疾病。我们已在3个家系中记录了该病作为常染色体显性性状的家族性传播。9名受影响个体中有7名(78%)出现了掌腱膜挛缩,这比散发病例报告的平均0%有显著增加,表明在这些家族中,这两种纤维化疾病是同一基因的多效性效应。同样,90%的佩罗尼氏病患者存在组织相容性B7交叉反应抗原。需要进行更多研究,包括详细的家族史和组织相容性抗原分型,以阐明组织相容性抗原作为相对危险因素的作用。

相似文献

1
Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompatibility B7 cross-reacting antigens.一种具有常染色体显性遗传的佩罗尼氏病遗传形式的鉴定及其与掌腱膜挛缩症和组织相容性B7交叉反应抗原的关联。
J Urol. 1982 Jul;128(1):48-51. doi: 10.1016/s0022-5347(17)52751-2.
2
Peyronie's disease: a newly recognized autosomal-dominant trait.佩罗尼氏病:一种新发现的常染色体显性性状。
Am J Med Genet. 1982 Jun;12(2):227-35. doi: 10.1002/ajmg.1320120213.
3
Non-association of Peyronie's disease with HLA B7 cross-reactive antigens.佩罗尼氏病与HLA B7交叉反应抗原无关联。
J Urol. 1982 Jun;127(6):1223-4. doi: 10.1016/s0022-5347(17)54302-5.
4
HLA antigens in Peyronie's disease.佩罗尼氏病中的人类白细胞抗原
Urol Int. 1994;52(1):34-7. doi: 10.1159/000282566.
5
HLA association of idiopathic Peyronie's disease: an indication of autoimmune phenomena in etiopathogenesis?特发性佩罗尼氏病与人类白细胞抗原的关联:病因发病机制中自身免疫现象的一个指征?
Tissue Antigens. 1991 Sep;38(3):104-6. doi: 10.1111/j.1399-0039.1991.tb02021.x.
6
Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture.佩罗尼氏病与掌腱膜挛缩症之间基因表达谱的比较。
Int Braz J Urol. 2004 Jul-Aug;30(4):349-50. doi: 10.1590/s1677-55382004000400019.
7
The genetic and bacteriological aspects of Peyronie's disease.佩罗尼氏病的遗传学和细菌学方面
J Urol. 1997 Jan;157(1):291-4.
8
Patients with Dupuytren's Contracture, Ledderhose Disease, and Peyronie's Disease are at higher risk of arthrofibrosis following total knee arthroplasty.患有杜普伊特伦挛缩症、莱德霍斯病和佩罗尼病的患者在接受全膝关节置换术后发生关节纤维组织挛缩的风险更高。
Knee. 2021 Mar;29:190-200. doi: 10.1016/j.knee.2021.02.009. Epub 2021 Feb 25.
9
The association of Peyronie's disease with HLA B7 cross-reactive antigens. A case report of identical twins.佩罗尼氏病与HLA B7交叉反应抗原的关联。一对同卵双胞胎的病例报告。
Cleve Clin J Med. 1987 Sep-Oct;54(5):427-30. doi: 10.3949/ccjm.54.5.427.
10
Peyronie's disease and Dupuytren's contracture secondary to topical timolol.局部应用噻吗洛尔继发佩罗尼氏病和掌腱膜挛缩症
Int Ophthalmol. 2019 Mar;39(3):683-685. doi: 10.1007/s10792-018-0837-y. Epub 2018 Feb 8.

引用本文的文献

1
[Current treatment concepts for Peyronie's disease].[佩罗尼氏病的当前治疗理念]
Urologie. 2023 Dec;62(12):1332-1342. doi: 10.1007/s00120-023-02213-2. Epub 2023 Nov 3.
2
Peyronie's Disease: A Brief Overview.佩罗尼氏病:简要概述
Cureus. 2023 Apr 2;15(4):e37037. doi: 10.7759/cureus.37037. eCollection 2023 Apr.
3
Significant familial clustering of Peyronie's disease in close and distant relatives.在近亲及远亲中,存在显著的 Peyronie 病家族聚集性。
Andrology. 2022 Oct;10(7):1361-1367. doi: 10.1111/andr.13223. Epub 2022 Jul 13.
4
The contribution of the immune system to genitourinary fibrosis.免疫系统对泌尿生殖系统纤维化的贡献。
Exp Biol Med (Maywood). 2022 May;247(9):765-778. doi: 10.1177/15353702221090872. Epub 2022 May 7.
5
Peyronie's disease: is it genetic or not?佩罗尼氏病:它有遗传性吗?
Transl Androl Urol. 2020 Mar;9(Suppl 2):S262-S268. doi: 10.21037/tau.2019.10.21.
6
Increased Risk of Cancer in Men With Peyronie's Disease: A Cohort Study Using a Large United States Insurance Claims Database.佩罗尼氏病男性患癌风险增加:一项使用美国大型保险理赔数据库的队列研究。
Sex Med. 2019 Dec;7(4):403-408. doi: 10.1016/j.esxm.2019.08.007. Epub 2019 Sep 14.
7
A review of inflammation and fibrosis: implications for the pathogenesis of Peyronie's disease.炎症与纤维化的综述:对佩罗尼氏病发病机制的影响。
World J Urol. 2020 Feb;38(2):253-261. doi: 10.1007/s00345-019-02815-6. Epub 2019 Jun 12.
8
Urologic conditions associated with malignancy.与恶性肿瘤相关的泌尿系统疾病。
Urol Oncol. 2020 Jan;38(1):23-30. doi: 10.1016/j.urolonc.2018.12.018. Epub 2019 Jan 2.
9
The Genetic Basis of Peyronie Disease: A Review.《佩罗尼病的遗传学基础:综述》。
Sex Med Rev. 2016 Jan;4(1):85-94. doi: 10.1016/j.sxmr.2015.10.002. Epub 2016 Jan 8.
10
Collagenase Clostridium histolyticum in the management of Peyronie's disease: a review of the evidence.溶组织梭状芽孢杆菌胶原酶治疗佩罗尼氏病:证据综述
Ther Adv Urol. 2016 Jun;8(3):192-202. doi: 10.1177/1756287216637569. Epub 2016 Mar 22.